Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases

被引：65

作者：

Calabrese, Leonard ^{[1
]}

Velcheti, Vamsidhar ^{[2
]}

机构：

[1] Cleveland Clin, Dept Rheumatol Immunol, 9500 Euclid Dr, Cleveland, OH 44106 USA

[2] Cleveland Clin, Dept Hematol & Oncol, Cleveland, OH 44106 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷 / 01期

关键词：

T-CELL EXHAUSTION; ANTI-CTLA-4; ANTIBODIES; IPILIMUMAB; INFECTION; DISORDERS; MELANOMA;

D O I：

10.1136/annrheumdis-2016-209782

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1 / 3

页数：3

共 18 条

[1]

Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection [J].

Blackburn, Shawn D. ;

Shin, Haina ;

Haining, W. Nicholas ;

Zou, Tao ;

Workman, Creg J. ;

Polley, Antonio ;

Betts, Michael R. ;

Freeman, Gordon J. ;

Vignali, Dario A. A. ;

Wherry, E. John .

NATURE IMMUNOLOGY, 2009, 10 (01) :29-37

[2]

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination [J].

Boutros, Celine ;

Tarhini, Ahmad ;

Routier, Emilie ;

Lambotte, Olivier ;

Ladurie, Francois Leroy ;

Carbonnel, Franck ;

Izzeddine, Hassane ;

Marabelle, Aurelien ;

Champiat, Stephane ;

Berdelou, Armandine ;

Lanoy, Emilie ;

Texier, Matthieu ;

Libenciuc, Cristina ;

Eggermont, Alexander M. M. ;

Soria, Jean-Charles ;

Mateus, Christine ;

Robert, Caroline .

NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) :473-486

[3]

COLEY VACCINE AND TNF THERAPY [J].

BROUCKAERT, PGG ;

FIERS, W ;

LEJEUNE, FJ .

NATURE, 1992, 358 (6388) :630-630

[4]

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab [J].

Cappelli, Laura C. ;

Gutierrez, Anna Kristina ;

Baer, Alan N. ;

Albayda, Jemima ;

Manno, Rebecca L. ;

Haque, Uzma ;

Lipson, Evan J. ;

Bleich, Karen B. ;

Shah, Ami A. ;

Naidoo, Jarushka ;

Brahmer, Julie R. ;

Le, Dung ;

Bingham, Clifton, III .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :43-50

[5]

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders [J].

Johnson, Douglas B. ;

Sullivan, Ryan J. ;

Ott, Patrick A. ;

Carlino, Matteo S. ;

Khushalani, Nikhil I. ;

Ye, Fei ;

Guminski, Alexander ;

Puzanov, Igor ;

Lawrence, Donald P. ;

Buchbinder, Elizabeth I. ;

Mudigonda, Tejaswi ;

Spencer, Kristen ;

Bender, Carolin ;

Lee, Jenny ;

Kaufman, Howard L. ;

Menzies, Alexander M. ;

Hassel, Jessica C. ;

Mehnert, Janice M. ;

Sosman, Jeffrey A. ;

Long, Georgina V. ;

Clark, Joseph I. .

JAMA ONCOLOGY, 2016, 2 (02) :234-240

[6]

Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]

[7]

Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators [J].

Le Mercier, Isabelle ;

Lines, J. Louise ;

Noelle, Randolph J. .

FRONTIERS IN IMMUNOLOGY, 2015, 6

[8]

Immune-Related Adverse Events From Immune Checkpoint Inhibitors [J].

Marrone, K. A. ;

Ying, W. ;

Naidoo, J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) :242-251

[9]

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection [J].

McKinney, Eoin F. ;

Lee, James C. ;

Jayne, David R. W. ;

Lyons, Paul A. ;

Smith, Kenneth G. C. .

NATURE, 2015, 523 (7562) :612-+

[10]

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor [J].

Nishimura, H ;

Nose, M ;

Hiai, H ;

Minato, N ;

Honjo, T .

IMMUNITY, 1999, 11 (02) :141-151

← 1 2 →